Milestone
Bioprocess Technology

Following the trend towards biopharmaceutical medicine Sartorius launched for its ambr 250 modular benchtop automated mini bioreactor system new vessels, which are designed for gentle stirring and optimum growth of cell lines. The system allows cost-effective, scalable process development of cell and gene therapies.

The new software saves time with functionality, modelling and data pre-processing. It also makes model data easier to interpret for better process control and mines data to help optimise product quality, resource use and cost efficiency.

Sartorius was once again a double award winner at the Fisher Scientific European Sales Conference in Karpacz, Poland, retaining the same awards won in 2018, European Excellence and Supplier Best Booth.

The focus of Sartorius' third Research Xchange Forum (RXF2019) on April 25, 2019 will be on Car-T cell therapy. By organizing this event, the company intends to promote interdisciplinary exchange and foster potential collaborations between academia and industry on highly promising scientific fields relevant to both scientists and businesses.

Sartorius Stedim Biotech and Novasep have entered into a collaboration agreement in the area of chromatography and single-use bioprocessing. The joint systems are to provide an alternative to batch and continuous resin-based chromatography.

Sartorius Stedim Biotech introduces Biostat RM TX with Flexsafe RM TX for developing consistent quality cellular products. The company showcased its innovations at the recently held Phacilitate Leaders World 2019 event in Miami, USA.

Sartorius Stedim Biotech (SSB) announced the launch of services for new biological entities, called NBE Product Characterization. The company provides a comprehensive range of testing for innovator molecules available either as off-the-shelf assays or custom assay development for more complex proteins.

Sartorius Stedim Biotech launched a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies. The new GMP platform, which combines the single-use Flexsafe bag technology with the company’s expertise in biopharmaceutical automation, was introduced at Phacilitate Leaders World 2019 in Miami.